Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Potential symbols : RETA save search
RETA FRAUD ALERT: Jakubowitz Law is Investigating Reata Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws
Published: 2023-06-09 (Crawled : 10:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.15%
H: 0.96%
C: -0.17%
potential
RETA ALERT: The Law Offices of Vincent Wong Investigate Reata Pharmaceuticals, Inc. for Potential Violations of Securities Laws
Published: 2023-05-31 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.02%
H: 1.4%
C: 0.37%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: 0.88%
H: 4.78%
C: 2.26%
potential
TCBI ALERT: The Law Offices of Vincent Wong Investigate Texas Capital Bancshares, Inc. for Potential Violations of Securities Laws
Published: 2023-05-31 (Crawled : 09:00) - prnewswire.com
TCBI | News | $60.1 -0.1% -0.1% 300K
|
Finance
|
| O: -0.31%
H: 0.33%
C: -3.51%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.02%
H: 1.4%
C: 0.37%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: 0.88%
H: 4.78%
C: 2.26%
potential
PHAT ALERT: The Law Offices of Vincent Wong Investigate Phathom Pharmaceuticals, Inc. for Potential Violations of Securities Laws
Published: 2023-05-31 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.02%
H: 1.4%
C: 0.37%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: 0.88%
H: 4.78%
C: 2.26%
potential
RETA FRAUD ALERT: Jakubowitz Law is Investigating Reata Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws
Published: 2023-05-30 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.34%
H: 0.55%
C: -2.5%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: 0.26%
H: 2.71%
C: -3.31%
potential
PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws
Published: 2023-05-30 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.34%
H: 0.55%
C: -2.5%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: 0.26%
H: 2.71%
C: -3.31%
potential
CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.09%
H: 3.99%
C: 3.0%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 32.07%
H: 1.89%
C: -24.85%
treatment fda ongoing trial approval berubicin potential
CNS Pharmaceuticals Announces Presentation of Ongoing Potentially Pivotal Berubicin Clinical Trial Design at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting
Published: 2022-06-08 (Crawled : 13:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -1.36%
H: 6.26%
C: 1.73%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 0.98%
H: 3.23%
C: -0.9%
ongoing trial presentation berubicin potential designation
CNS Pharmaceuticals Receives Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 2.2%
H: 0.68%
C: -0.26%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 8.65%
H: 0.0%
C: -6.34%
treatment approval berubicin potential glioblastoma
CNS Pharmaceuticals Receives Approval from France Ethics Committee and Competent Authority for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2022-04-06 (Crawled : 13:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -1.09%
H: 1.8%
C: 0.45%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 5.16%
H: 7.69%
C: 6.16%
treatment approval berubicin potential glioblastoma
CNS Pharmaceuticals Receives Approval from Competent Authority of Switzerland for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2022-04-05 (Crawled : 14:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.63%
H: 1.09%
C: -2.15%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 0.24%
H: 29.56%
C: 14.4%
treatment approval berubicin switzerland potential glioblastoma
CNS Pharmaceuticals Receives Approval from Switzerland Ethics Committee for its Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2021-12-02 (Crawled : 15:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.27%
H: 3.46%
C: -5.38%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 10.38%
H: 0.0%
C: -8.55%
treatment approval berubicin potential switzerland glioblastoma
CNS Pharmaceuticals Doses First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2021-09-30 (Crawled : 12:15) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.64%
H: 1.89%
C: -5.08%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: -3.75%
H: 3.9%
C: -3.25%
berubicin treatment fda potential fast track drug designation glioblastoma
CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
Published: 2021-05-19 (Crawled : 15:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 13.45%
H: 9.49%
C: 9.11%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 0.0%
H: 3.19%
C: -1.06%
berubicin potential enroll
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.